Version history

{
  "session_id": "sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-005103",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n# Mechanistic Hypotheses: Microglial OxPC Neutralization in MS\n\n## 1. ApoE-Mediated Lipid Sequestration and Efflux\n\n**Mechanism:** Microglia upregulate apolipoprotein E (ApoE) as a lipid shuttle to bind and sequester toxic OxPC species, then utilize ABCA1/ABCG1 transporters to efflux these complexes. ApoE's 2-3 helix domain directly coordinates the oxidized fatty acid tails of OxPCs, preventing them from inserting into neuronal/oligodendrocyte membranes. This creates a microglial \"lipid sink\" that protects vulnerable myelinating cells.\n\n**Key Evidence:** Microglial ApoE expression is dramatically induced in MS lesions and surrounding white matter (PMID: 33603230), and ApoE directly binds oxidized phospholipids with micromolar affinity. ABCA1-dependent cholesterol efflux is the rate-limiting step for ApoE lipidation and function.\n\n**Testable Prediction:** Conditional deletion of *Apoe* in microglia (CX3CR1-CreER; *Apoe* flox/flox) should cause OxPC accumulation in cerebrospinal fluid, accelerated oligodendrocyte loss, and impaired motor function in cuprizone or MOG-EM demyelination models compared to littermate controls.\n\n**Target:** APOE (protein)\n\n---\n\n## 2. Nrf2-ARE Transcriptional Activation of Antioxidant Detoxification Enzymes\n\n**Me",
  "tokens_used": "314"
}